Skip to content
★ Sign in to follow
RT

R. Timmis Ware

Albireo Pharma, Inc.
Total declarations
104
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (100 ops.)
€728k

Latest filing published 21 Apr 2008 for Albireo Pharma, INC., €24k.

Insider track record

Disclosed buys
0
Disclosed sells
100
Signal history

No signal scores available.

R. Timmis Ware: trading record in brief

R. Timmis Ware discloses dealings in Albireo Pharma, Inc. to SEC (Form 4). In total, 104 filings cover trades dated from 16 May 2007 to 17 April 2008.

Every open-market trade on record is a sale: 100 sales worth €728k. Besides market trades, the filings include 2 option exercises. Since January 2008: no purchases and 100 sales on the market.

The latest filing, published on 21 April 2008, reports an option exercise of €24k in Albireo Pharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to R. Timmis Ware

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations104 total

25 of 104 declarations